Asymchem Laboratories (Tianjin) Co., Ltd. (HKG:6821)

Market Cap	43.92B
Revenue (ttm)	6.90B
Net Income (ttm)	1.17B
Shares Out	n/a
EPS (ttm)	3.26
PE Ratio	37.56
Forward PE	30.58
Dividend	1.20 (1.29%)
Ex-Dividend Date	Jun 25, 2025

Volume	720,862
Average Volume	842,783
Open	93.50
Previous Close	93.50
Day's Range	92.30 - 99.65
52-Week Range	39.95 - 116.60
Beta	0.23
RSI	48.40
Earnings Date	Oct 29, 2025

About HKG:6821

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers process development and optimization, analytical, and scale-up services for small molecule drug products throughout the pre-clinical and clinical stage; and ton-scale manufacturing services for registered starting materials, advanced intermediates, and active pharmaceutical ingredients. It also engages in pre-formulation and formulation development; provision of chemical m...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 9,595
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6821

Financial Performance

In 2024, HKG:6821's revenue was 5.80 billion, a decrease of -25.82% compared to the previous year's 7.83 billion. Earnings were 948.95 million, a decrease of -58.17%.

Financial numbers in CNY